MGP and melanoma: Overshadowed for many years by efforts to find efficacious immunotherapies for advanced melanoma, and more recently by the focus on molecular therapy to target BRAF-mutated melanomas, considerably less attention has been paid to genes that are not only upregulated to high levels in advanced melanoma, but also play a pertinent role in protecting VGP and MGP melanomas from apoptosis.